Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Testimony by otolaryngologists in defense of tobacco companies 2009-2014.

Jackler RK.

Laryngoscope. 2015 Dec;125(12):2722-9. doi: 10.1002/lary.25432. Epub 2015 Jul 17.

2.
3.

Potential reduced exposure products (PREPs) in industry trial testimony.

Wayne GF.

Tob Control. 2006 Dec;15 Suppl 4:iv90-7. Review.

4.

Economics on trial: the use and abuse of economic methods in third party tobacco litigation.

Max W, Tsoukalas T.

Tob Control. 2006 Dec;15 Suppl 4:iv77-83. Review.

5.

Challenging the epidemiologic evidence on passive smoking: tactics of tobacco industry expert witnesses.

Francis JA, Shea AK, Samet JM.

Tob Control. 2006 Dec;15 Suppl 4:iv68-76. Review.

6.

The role of tobacco advertising and promotion: themes employed in litigation by tobacco industry witnesses.

Goldberg ME, Davis RM, O'Keefe AM.

Tob Control. 2006 Dec;15 Suppl 4:iv54-67. Review.

7.

How the health belief model helps the tobacco industry: individuals, choice, and "information".

Balbach ED, Smith EA, Malone RE.

Tob Control. 2006 Dec;15 Suppl 4:iv37-43.

8.

Tobacco industry litigation position on addiction: continued dependence on past views.

Henningfield JE, Rose CA, Zeller M.

Tob Control. 2006 Dec;15 Suppl 4:iv27-36. Review.

9.

Tobacco manufacturers' defence against plaintiffs' claims of cancer causation: throwing mud at the wall and hoping some of it will stick.

Milberger S, Davis RM, Douglas CE, Beasley JK, Burns D, Houston T, Shopland D.

Tob Control. 2006 Dec;15 Suppl 4:iv17-26.

Supplemental Content

Support Center